Immunization Clinical Trials

Study of Eltrombopag vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

The purpose of this study is to determine if Eltrombopag is as effective of a treatment for patients with newly diagnosed Immune Thrombocytopenia (ITP) when compared to standard treatment.

Clinical Outcomes and Host Immune Response in Vascular Graft and Endograft Infections (ACHIEVE)

ACHIEVE is a prospective observational cohort and biobank study of patients with suspected or diagnosed central vascular graft or endograft infection. The study also includes patients undergoing elective central vascular graft or endograft implantation and healthy blood donor controls. Participants undergo longitudinal clinical data collection and biospecimen sampling. The study …

BMT CTN 1703/1801: A Randomized, Multi-Center, Phase III Trial of Tacrolimus/ Methotrexate versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (PROGRESS III)/Companion Study: Microbiome and Immune Reconstitution in Cellular Therapies and Hematopoietic Stem Cell Transplantation (Mi-Immune)

The primary objective of the trial is to compare 1 year GVHD-free, relapse-free survival (GRFS) between the two GVHD prophylaxis regimens.

Development of Immunity after SARS-CoV Exposure and Recovery (DISCOVER)

Researchers at the Indiana University School of Medicine are studying COVID-19, and are currently seeking individuals who identify as African American/Black or Hispanic/Latino.  In Indiana and across the US, COVID-19 has had the worst impact on Black and Hispanic people.  For this reason, we asking people who identify as Black …

SEEKING COVID POSITIVE VOLUNTEERS Development of Immunity After SARS-COV Exposure and Recovery (DISCOVER)

Researchers at the Indiana University School of Medicine are studying COVID-19 and are seeking individuals who have been clinically diagnosed as COVID positive.  

A Study to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease

BAN2401 is an investigational study drug which is being studied in people who have early AD (Alzheimer's disease), with mild cognitive (thinking) impairment or mild dementia. People with AD have a build-up of abnormal protein known as amyloid in their brains.  This build up may lead to impairment in memory …

None

None

None

None